WebFDA label information for this drug is available at DailyMed. Use in Cancer Ondansetron hydrochloride is approved to prevent: Nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. It is used in adults and children. Ondansetron hydrochloride is also being studied in the treatment of other conditions. WebMay 5, 2015 · The active ingredient in ondansetron orally disintegrating tablets is ondansetron base, ... DailyMed will deliver this notification to your desktop, Web …
Ondansetron - mobile.fpnotebook.com
WebOndansetron may be taken up to 3 times a day for 1 to 2 days after your chemotherapy or radiation treatment is finished. If you are taking this medication on a prescribed schedule, … Webnausea/vomiting prevention, chemo-related. [IV route, highly- or moderately-emetogenic chemo] Dose: 0.15 mg/kg/dose IV q4h x3 doses; Start: 30min before chemo; Max: 16 mg/dose. [PO route, highly-emetogenic chemo] Dose: 24 mg PO x1 30min before chemo; Info: use for single-day chemo regimens. [PO route, moderately-emetogenic chemo] siang electrical jawi
Ondansetron: 7 things you should know - Drugs.com
WebAug 5, 2024 · The more common side effects of ondansetron can include: headache. diarrhea. constipation. dizziness. drowsiness. If these effects are mild, they may go away … WebHYDROXYZINE HYDROCHLORIDE tablet, film coated. NDC Code (s): 51655-467-52. Packager: Northwind Pharmaceuticals, LLC. This is a repackaged label. Source NDC Code (s): 0093-5062. Category: HUMAN PRESCRIPTION DRUG LABEL. DEA Schedule: None. Marketing Status: Abbreviated New Drug Application. WebZOFRAN (ondansetron hydrochloride) tablets, for oral use ZOFRAN ODT (ondansetron) orally disintegrating tablets ZOFRAN (ondansetron hydrochloride) oral solution Initial U.S. Approval: 1991 . INDICATIONS AND USAGE ZOFRAN is a 5-HT 3 receptor antagonist indicated for the prevention of: • nausea and vomiting associated with highly emetogenic … the pensione perth